After Your Series A: Board Seats and Investor Veto Rights
A priced round can change what founders can still decide.
After a priced Series A, the trap is that founders keep assuming their common stake still lets them run the company. The rule is that control now depends on who sits on the board and which actions need preferred approval. If you hold common stock, your power is no longer a simple ownership percentage. It is a map of seats, veto rights, and vote thresholds.
The board, not the shareholder vote, runs the company
Delaware corporate law, under DGCL Section 141(a), gives the board, not the stockholders, management of the corporation's business and affairs. A founder can hold a large common stake and still be outvoted on the board. The shareholder vote may still matter, but it does not run the company day to day between votes. Board composition is the first control question, because it tells you who hears the proposal, asks questions, and votes on company actions.
A Series A board is a stock-class map
In a traditional priced Series A, the board expands so the lead investor gets a seat, while the remaining seats stay for common shareholders. In most venture-backed startups, the parties negotiate board size and composition during funding rounds, and they can make those changes a condition to closing for new capital. Read the board as a stock-class list, not a list of friendly names. The work is to see which seats belong to the preferred side and which belong to the common side.
If you are an early employee with common stock, your practical influence is usually indirect. You can support a founder candidate, but the board still makes the calls. If you are a founder, the question is not just how many shares you keep. It is how many board seats you can still fill, and whether the preferred side can block the moves you want.
Protective provisions tell you what preferred can block
The NVCA Model Certificate of Incorporation, a model charter used by venture-backed startups, lets preferred stockholders approve certain actions that the board would otherwise handle alone, including dividend declarations, new debt, and cryptocurrency token issuance. A typical preferred protective provision is often bypassed when 50% of the preferred stock votes in favor. Read the protective provisions as a list of actions the preferred side can stop. If an action is on that list, the board's approval is not enough. If one investor holds most of the preferred, that threshold can give the investor a practical veto.
Veto rights that operate at board level often live in an investor rights agreement, a side contract between the company and its investors, or in another document, not in the charter. That placement matters. A founder may read the certificate and see one set of approval rights, while the investor rights agreement adds another set. Before signing, ask for the board seat allocation by stock class, the list of protected actions, and the preferred vote threshold. Ask which document carries each item, so you can see the full list in the deal papers before closing.
Promised seats do not promise outcomes
The Delaware Chancery Court, in West Palm Beach Firefighters’ Pension Fund v. Moelis & Company, struck down stockholder agreement terms that forced a board to elect a particular director, treating them as unlawful limits on the board's management power under DGCL Section 141(a). A board seat is a right to be considered, not a guaranteed outcome. A founder can be elected, but the board can still vote differently on company actions. Founder influence after a priced round is less about raw ownership and more about board math plus preferred approval rights.
Keep this board-control map in front of you when you review the documents:
- List the board seats by stock class.
- List the actions that require preferred approval.
- Note the preferred vote threshold needed to approve or block each action.
